Lixte Biotech Hlds
(LIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,466 | -1,485 | -710 | -3,586 | -2,968 |
| Accounts payable and accrued liabilities | 96 | 36 | 57 | -74 | -91 |
| Other Working Capital | 111 | 41 | 41 | -75 | 62 |
| Other Operating Activity | 1,276 | 352 | 43 | 570 | 431 |
| Operating Cash Flow | $-1,983 | $-1,056 | $-569 | $-3,165 | $-2,566 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -2,637 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -2,637 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-2,637 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,469 | 914 | 914 | N/A | N/A |
| Other Financing Activity | 0 | -10 | 0 | 0 | 0 |
| Financing Cash Flow | $6,469 | $904 | $914 | $N/A | $N/A |
| Beginning Cash Position | 1,039 | 1,039 | 1,039 | 4,204 | 4,204 |
| End Cash Position | 2,888 | 887 | 1,385 | 1,039 | 1,638 |
| Net Cash Flow | $1,849 | $-152 | $346 | $-3,165 | $-2,566 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,983 | -1,056 | -569 | -3,165 | -2,566 |
| Free Cash Flow | -1,983 | -1,056 | -569 | -3,165 | -2,566 |